<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32557621</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>07</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>07</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1399-0004</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>98</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical genetics</Title>
          <ISOAbbreviation>Clin Genet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Novel PCNT variants in MOPDII with attenuated growth restriction and pachygyria.</ArticleTitle>
        <Pagination>
          <StartPage>282</StartPage>
          <EndPage>287</EndPage>
          <MedlinePgn>282-287</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/cge.13797</ELocationID>
        <Abstract>
          <AbstractText>Biallelic loss-of-function mutations in the centrosomal pericentrin gene (PCNT) cause microcephalic osteodysplastic primordial dwarfism type II (MOPDII), which is characterized by extreme growth retardation, microcephaly, skeletal dysplasia, and dental anomalies. Life expectancy is reduced due to a high risk of cerebral vascular anomalies. Here, we report two siblings with MOPDII and attenuated growth restriction, and pachygyria. Compound heterozygosity for two novel truncated PCNT variants was identified. Both truncated PCNT proteins were expressed in patient's fibroblasts, with a reduced total protein amount compared to control. Patient's fibroblasts showed impaired cell cycle progression. As a novel finding, 20% of patient's fibroblasts were shown to express PCNT comparable to control. This was associated with normal mitotic morphology and normal co-localization of mutated PCNT with centrosome-associated proteins γ-tubulin and centrin 3, suggesting some residual function of truncated PCNT proteins. These data expand the clinical and molecular spectrum of MOPDII and indicate that residual PCNT function might be associated with attenuated growth restriction in MOPDII.</AbstractText>
          <CopyrightInformation>© 2020 The Authors. Clinical Genetics published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Waich</LastName>
            <ForeName>Stephanie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics and Adolescent Medicine, Division of Pediatric Pulmonology, Allergology and Endocrinology, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Janecke</LastName>
            <ForeName>Andreas R</ForeName>
            <Initials>AR</Initials>
            <Identifier Source="ORCID">0000-0001-7155-0315</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Parson</LastName>
            <ForeName>Walther</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Legal Medicine, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Forensic Science Program, The Pennsylvania State University, University Park, Pennsylvania, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Greber-Platzer</LastName>
            <ForeName>Susanne</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics and Adolescent Medicine, Division of Pediatric Pulmonology, Allergology and Endocrinology, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Müller</LastName>
            <ForeName>Thomas</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huber</LastName>
            <ForeName>Lukas A</ForeName>
            <Initials>LA</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cell Biology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Valovka</LastName>
            <ForeName>Taras</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vodopiutz</LastName>
            <ForeName>Julia</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-8087-7026</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics and Adolescent Medicine, Division of Pediatric Pulmonology, Allergology and Endocrinology, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>07</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Clin Genet</MedlineTA>
        <NlmUniqueID>0253664</NlmUniqueID>
        <ISSNLinking>0009-9163</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000941">Antigens</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014404">Tubulin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C086178">pericentrin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C565898">Microcephalic Osteodysplastic Primordial Dwarfism, Type II</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000941" MajorTopicYN="N">Antigens</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018385" MajorTopicYN="N">Centrosome</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004392" MajorTopicYN="N">Dwarfism</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005317" MajorTopicYN="N">Fetal Growth Retardation</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054082" MajorTopicYN="N">Lissencephaly</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073658" MajorTopicYN="N">Loss of Function Mutation</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008831" MajorTopicYN="N">Microcephaly</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010009" MajorTopicYN="N">Osteochondrodysplasias</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D035781" MajorTopicYN="N">Siblings</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014404" MajorTopicYN="N">Tubulin</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">MOPDII</Keyword>
        <Keyword MajorTopicYN="Y">microcephalic osteodysplastic primordial dwarfism type II</Keyword>
        <Keyword MajorTopicYN="Y">normal mitotic morphology</Keyword>
        <Keyword MajorTopicYN="Y">pachygyria</Keyword>
        <Keyword MajorTopicYN="Y">pericentrin</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32557621</ArticleId>
        <ArticleId IdType="pmc">PMC7497047</ArticleId>
        <ArticleId IdType="doi">10.1111/cge.13797</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Hall JG, Flora C, Scott CI, Pauli RM, Tanaka KI. Majewski osteodysplastic primordial dwarfism type II (MOPD II): natural history and clinical findings. Am J Med Genet A. 2004;130A:55‐72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15368497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rauch A, Thiel CT, Schindler D, et al. Mutations in the pericentrin (PCNT) gene cause primordial dwarfism. Science. 2008;319:816‐819.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18174396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bober MB, Niiler T, Duker AL, et al. Growth in individuals with Majewski osteodysplastic primordial dwarfism type II caused by pericentrin mutations. Am J Med Genet A. 2012;158A:2719‐2725.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22821869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bober MB, Jackson AP. Microcephalic Osteodysplastic primordial dwarfism, type II: a clinical review. Curr Osteoporos Rep. 2017;15:61‐69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5561166</ArticleId>
            <ArticleId IdType="pubmed">28409412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Delaval B, Doxsey SJ. Pericentrin in cellular function and disease. J Cell Biol. 2010;188:181‐190.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2812529</ArticleId>
            <ArticleId IdType="pubmed">19951897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Griffith E, Walker S, Martin CA, et al. Mutations in pericentrin cause Seckel syndrome with defective ATR‐dependent DNA damage signaling. Nat Genet. 2008;40:232‐236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2397541</ArticleId>
            <ArticleId IdType="pubmed">18157127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Delaval B, Doxsey S. Genetics. Dwarfism, where pericentrin gains stature. Science. 2008;319:732‐733.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18258883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dictenberg JB, Zimmerman W, Sparks CA, et al. Pericentrin and gamma‐tubulin form a protein complex and are organized into a novel lattice at the centrosome. J Cell Biol. 1998;141:163‐174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2132723</ArticleId>
            <ArticleId IdType="pubmed">9531556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ozawa H, Takayama C, Nishida A, Nagai T, Nishimura G, Higurashi M. Pachygyria in a girl with microcephalic osteodysplastic primordial short stature type II. Brain Dev. 2005;27:237‐240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15737708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Endoh‐Yamagami S, Karkar KM, May SR, et al. A mutation in the pericentrin gene causes abnormal interneuron migration to the olfactory bulb in mice. Dev Biol. 2010;340:41‐53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20096683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pierce MJ, Morse RP. The neurologic findings in Taybi‐Linder syndrome (MOPD I/III): case report and review of the literature. Am J Med Genet A. 2012;158A:606‐610.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22302400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Breuss M, Heng JI, Poirier K, et al. Mutations in the beta‐tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. Cell Rep. 2012;2:1554‐1562.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3595605</ArticleId>
            <ArticleId IdType="pubmed">23246003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Breuss MW, Leca I, Gstrein T, Hansen AH, Keays DA. Tubulins and brain development ‐ the origins of functional specification. Mol Cell Neurosci. 2017;84:58‐67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28347630</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
